http://www.bdsi.com
BioDelivery Sciences International, Inc. Company Intro
A company dedicated to driving innovative solutions for the treatment of serious and debilitating chronic conditions.
Industry
Healthcare
BioDelivery Sciences International, Inc. Headquaters
4131 ParkLake Avenue
Raleigh,27612
United States
BioDelivery Sciences International, Inc. Share price
19 Oct 2020 01:11 GMT
$3.7500
-0.01 (-0.27 %)
BioDelivery Sciences International, Inc. Market cap
$372.446 M
WMC RANKING
2020
BioDelivery Sciences International, Inc. # 44
BiotechnologyLatest BioDelivery Sciences International, Inc. News
18 Oct 2020
Global Osteoarthritis Treatment Market : Post-Pandemic ...
Global Osteoarthritis Treatment Market report presents the fundamental industry insights and market statistics. ... BioDelivery Sciences International, Inc
18 Oct 2020
3 Fast-Growing Small Caps to Consider
BioDelivery Sciences International. The second company to be under consideration is BioDelivery Sciences International Inc. (NASDAQ:BDSI), a Raleigh, North ...
19 Oct 2020
Diabetic Neuropathic Pain Drug Market to Perceive ...
BioDelivery Sciences International, Inc. Boehringer Ingelheim GmbH. Daiichi Sankyo Company, Limited Dong-A Socio Group Eli Lilly and Company Glenmark ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| BioDelivery Sciences International, Inc. | 2.01 | 0.60 | 2.21 | 0 | 0 | 0 | 2.06 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.32 | 100 | 20 | 0 | 0 | 96.20 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.68 | 33 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0.06 |
| Incyte Corporation | 40.27 | 8.70 | 7.11 | 100 | 0 | 0 | 84.84 |
BioDelivery Sciences International, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioDelivery Sciences International, Inc. | $111,389 | $86,063 | $-15,305 | $372.446M | 44 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.206B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $56.803B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.207B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.821B | 4 |